Prevalence of hepatitis D virus in chronic hepatitis B patients: findings from Poland
Advances in Medical Sciences · 2025
DOI: 10.1016/j.advms.2025.07.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Medical Sciences, 2025. Verfasst von Dorota Zarębska-Michaluk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis Delta Virus, Hepatitis D. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PURPOSE: This study aimed to determine the prevalence of hepatitis B/hepatitis D virus (HBV/HDV) co-infections in eastern Poland. MATERIALS/METHODS: We included consecutive patients with chronic hepatitis B treated with nucleos(t)ide analogues (NA) in the study, in whom we performed anti-HDV assays verified by molecular testing. RESULTS: The analysed population consisted of 398 patients, predominantly male with a median age of 50 years, 58.3 % of whom had comorbidities. Forty-three patients (10.8 %) were diagnosed with cirrhosis. Patients were treated with entecavir, tenofovir, or lamivudine for a median of 5 years. At the start of treatment, the median viral load was 5110 IU/ml, and 98 % of patients achieved viral eradication during the therapy. In the study population, anti-HDV antibodies were detected in 6 patients (1.5 %), 3 men and 3 women, of whom in 1 (0.25 %) the presence of genetic material of the HDV was confirmed by molecular testing. Among anti-HDV-positive patients, 3 (50 %) had cirrhosis, 1 of them underwent liver transplantation, and 2 had extrahepatic malignancy. All of them were negative for hepatitis B virus envelope (HBe) antigen and had antibodies to HBe antigen present at the beginning of antiviral treatment. All anti-HDV-positive patients achieved viral clearance during the therapy. CONCLUSION: In a population of almost four hundred patients infected with HBV, we observed a low prevalence of anti-HDV antibodies of 1.5 % and HDV replication of only 0.25 %. Half of the 6 patients with serologic evidence of co-infection had cirrhosis, so HDV likely played a role in disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland.
- Collegium Medicum, Jan Kochanowski University, Kielce, Poland. Electronic address: michal.brzdek@gmail.com.
- Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
- Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
- Clinical Department of Infectious Diseases with Hepatology Subdivision, Medical College of Rzeszow University, Rzeszow, Poland.
Zitieren
APA
Zarębska-Michaluk, D., Brzdęk, M., Dobrowolska, K., Martonik, D., Parfieniuk-Kowerda, A., Janczura, J., Brzdęk, K., Pleśniak, R., Piszcz, A., & Flisiak, R. (2025). Prevalence of hepatitis D virus in chronic hepatitis B patients: findings from Poland. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2025.07.003
Vancouver
Zarębska-Michaluk D, Brzdęk M, Dobrowolska K, Martonik D, Parfieniuk-Kowerda A, Janczura J, et al. Prevalence of hepatitis D virus in chronic hepatitis B patients: findings from Poland. Advances in Medical Sciences. 2025. doi:10.1016/j.advms.2025.07.003
BibTeX
@article{ZarbskaMichaluk2025,
author = {Zarębska-Michaluk, Dorota and Brzdęk, Michał and Dobrowolska, Krystyna and Martonik, Diana and Parfieniuk-Kowerda, Anna and Janczura, Jakub and Brzdęk, Kinga and Pleśniak, Robert and Piszcz, Agnes and Flisiak, Robert},
title = {Prevalence of hepatitis D virus in chronic hepatitis B patients: findings from Poland},
journal = {Advances in Medical Sciences},
year = {2025},
doi = {10.1016/j.advms.2025.07.003}
}
EUVIMED